skip to primary navigationskip to content
 

RebelBio opens call for London life-sciences accelerator - deadline 1 Dec 2017

last modified Nov 08, 2017 01:28 PM
RebelBio, the world’s first early-stage life-sciences accelerator, is seeking applications from ambitious scientists and entrepreneurs for its 2018 programmes. Science graduates, PhDs, postdocs and academics who feel a strong urge to commercialise their research or who need to advance their existing companies are particularly welcome.

More information from RebelBio 

Our investment  is given with the aim to develop a life-sciences product, commercialise research, or accelerate existing companies that can give the world something it needs.
RebelBio will invest up to $250K*, along with extensive business and scientific mentoring during the three-month period of the program, which take place in London from January 8th to April 8th 2018 & Corks programme from May - July.
 
During this time, RebelBio will provide laboratory space and supplies designed to allow our founders to move forward technically and business development. The program will culminate with a demo day and is part of an ongoing relationship that applicants will have with the world’s premier early-stage venture-capital fund, SOSV.
 
This relationship will provide many benefits including access to RebelBio’s vast network of investors, corporates and other like-minded entrepreneurs.
 

Application Information:

 

Deadlines:


The closing date for the London programme is December 1st 2017
The closing date for the Cork programme will be announced in early 2018.
 
Informal inquiries through contacting steven.oconnell@sosv.com.  
 
*Subject to performance
Filed under: ,

About

The Synthetic Biology Strategic Research Initiative provides a hub for anyone interested in Synthetic Biology at the University of Cambridge, including researchers, commercial partners and external collaborators. 

Subscribe to our mailing list